Millipore Extends Exclusive License Agreement with University of Dundee
News Oct 10, 2008
The ongoing collaboration, established in 1995 between the University of Dundee and Upstate Biotechnology (now part of Millipore), will enable Millipore to make such tools available to life science researchers worldwide.
The University of Dundee and the Medical Research Council (MRC) Protein Phosphorylation Unit have developed specific kinase and phosphatase methods and reagents for the study of cell signaling. As part of the extended license agreement, Millipore will have access to new research tools developed by Sir Philip Cohen, Director of the MRC Protein Phosphorylation Unit along with Vice Principal, Head of College Professor Peter Downes, and head of the university’s Inositol Signaling Laboratory.
“We are very pleased to extend our collaboration with the University of Dundee and look forward to commercializing innovative tools for this important field of research,” said Rick Ryan, Vice President of Millipore’s Bioscience Drug Discovery Business Unit. “Our relationship with the university is part of our long-term strategy to tap the expertise of leading academic institutions and bring innovative technologies and tools to our life science customers.”
Scleroderma Study Offers New Hope For SufferersNews
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study found. The approach could represent the first new treatment to improve survival in patients with severe scleroderma in more than four decades.READ MORE
Heart-muscle Patches Created from Human Cells Improve Recovery from Heart AttacksNews
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery from heart attack injury.READ MORE